by Biolexis | Apr 13, 2023 | News & Media
May 16-18, 2023 Biolexis CEO Dr. David J. Bearss to present MolecuLern technology at 22nd Annual Bio-IT World Conference & Expo taking place May 16-18, 2023, in Boston, MA. https://www.bio-itworldexpo.com/
by Biolexis | Apr 13, 2023 | News & Media
April 26-27, 2023 Biolexis CEO Dr. David J. Bearss to present MolecuLern technology at Ai-Driven Drug Development Summit Europe on April 26-27, 2023, in London. AI Driven Drug Development Summit Europe 2023 (aidrugdevelopmentsummiteu.com)
by Biolexis | Apr 13, 2023 | News & Media
April 14-19, 2023 Biolexis management participates and presents at the AACR (American Association of Cancer Research) Annual Meeting on April 14-19, 2023 – Orange County Convention Center, Orlando, Florida. AACR Annual Meeting...
by Biolexis | Apr 11, 2023 | News & Media
April 10-11, 2023 Biolexis Therapeutics CSO invited to present company MolecuLern™ technology at 2023 Annual San Antonio Drug Discovery Symposium held at Greehey Children’s Cancer Research Institute of University of Texas Health San Antonio....
by Biolexis | Apr 8, 2023 | News & Media
April 8-13, 2023 Biolexis management participated and presented pre-clinical data on CDK9 inhibitor at the AACR (American Association of Cancer Research) Annual Meeting on April 8-13, 2022, Ernest N. Morial Convention Center New Orleans, Louisiana. B137 / 13...
